Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

MicroRNAs involved in chemo- and radioresistance of high-grade gliomas

Andrej Besse, Jiri Sana, Pavel Fadrus, Ondrej Slaby

. 2013 ; 34 (4) : 1969-1978.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Persistent link   https://www.medvik.cz/link/bmc13031496

Grant support
NT11214 MZ0 CEP Register
NT13514 MZ0 CEP Register

High-grade gliomas (HGGs) are malignant primary brain tumors of glial cell origin. Despite optimal course of treatment, including maximal surgical resection followed by adjuvant chemo- and/or radiotherapy, the prognosis still remains poor. The main reason is the commonly occurring chemo- and radioresistance of these tumors. In recent years, several signaling pathways, especially PI3K/AKT and ATM/CHK2/p53, have been linked to the resistance of gliomas. Moreover, additional studies have shown that these pathways are significantly regulated by microRNAs (miRNAs), short endogenous RNA molecules that modulate gene expression and control many biological processes including apoptosis, proliferation, cell cycle, invasivity, and angiogenesis. MiRNAs are not only highly deregulated in gliomas, their expression signatures have also been shown to predict prognosis and therapy response. Therefore, they present promising biomarkers and therapeutic targets that might overcome the resistance to treatment and improve prognosis of glioma patients. In this review, we summarize the current knowledge of the functional role of miRNAs in gliomas resistance to chemo- and radiotherapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031496
003      
CZ-PrNML
005      
20191009123722.0
007      
ta
008      
131002s2013 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13277-013-0772-5 $2 doi
035    __
$a (PubMed)23568705
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Besse, Andrej $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
245    10
$a MicroRNAs involved in chemo- and radioresistance of high-grade gliomas / $c Andrej Besse, Jiri Sana, Pavel Fadrus, Ondrej Slaby
520    9_
$a High-grade gliomas (HGGs) are malignant primary brain tumors of glial cell origin. Despite optimal course of treatment, including maximal surgical resection followed by adjuvant chemo- and/or radiotherapy, the prognosis still remains poor. The main reason is the commonly occurring chemo- and radioresistance of these tumors. In recent years, several signaling pathways, especially PI3K/AKT and ATM/CHK2/p53, have been linked to the resistance of gliomas. Moreover, additional studies have shown that these pathways are significantly regulated by microRNAs (miRNAs), short endogenous RNA molecules that modulate gene expression and control many biological processes including apoptosis, proliferation, cell cycle, invasivity, and angiogenesis. MiRNAs are not only highly deregulated in gliomas, their expression signatures have also been shown to predict prognosis and therapy response. Therefore, they present promising biomarkers and therapeutic targets that might overcome the resistance to treatment and improve prognosis of glioma patients. In this review, we summarize the current knowledge of the functional role of miRNAs in gliomas resistance to chemo- and radiotherapy.
650    _2
$a apoptóza $7 D017209
650    _2
$a nádory mozku $x farmakoterapie $x genetika $x radioterapie $7 D001932
650    _2
$a proteiny buněčného cyklu $x metabolismus $7 D018797
650    _2
$a DNA vazebné proteiny $x metabolismus $7 D004268
650    _2
$a chemorezistence $x genetika $7 D019008
650    12
$a gliom $x farmakoterapie $x genetika $x radioterapie $7 D005910
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x genetika $x metabolismus $7 D035683
650    _2
$a invazivní růst nádoru $7 D009361
650    _2
$a fosfatidylinositol-3-kinasy $x metabolismus $7 D019869
650    _2
$a protein-serin-threoninkinasy $x metabolismus $7 D017346
650    _2
$a protoonkogenní proteiny c-akt $x metabolismus $7 D051057
650    _2
$a tolerance záření $x genetika $7 D011836
650    _2
$a nádorový supresorový protein p53 $x metabolismus $7 D016159
650    _2
$a nádorové supresorové proteiny $x metabolismus $7 D025521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Šána, Jiří $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic $7 xx0165776
700    1_
$a Fadrus, Pavel $u Department of Neurosurgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0123566
700    1_
$a Slabý, Ondřej, $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic $d 1981- $7 js20030220015
773    0_
$w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 34, č. 4 (2013), s. 1969-1978
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23568705 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20191009124139 $b ABA008
999    __
$a ok $b bmc $g 995583 $s 829941
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 34 $c 4 $d 1969-1978 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
GRA    __
$a NT11214 $p MZ0
GRA    __
$a NT13514 $p MZ0
LZP    __
$a Pubmed-20131002

Find record

Citation metrics

Archiving options